Unable to load price data. Sorry.

¯\_(ツ)_/¯

Edge Therapeutics Inc (NASDAQ:PDSB)

CAPS Rating: 4 out of 5

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQ:PDSB will perform against the market?

Add Stock to CAPS Watchlist

All Players

17 Outperform
3 Underperform
 

All-Star Players

10 Outperform
2 Underperform
 

Wall Street

0 Outperform
1 Underperform
 

Top NASDAQ:PDSB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TSIF (99.97)
Submitted March 28, 2018

Stopping a phase-3 trial due to lack of possible success is brutal on small cap bios. Need to check the pipeline. Cash about $2 per share. Often, pipeline on a small cap is all related on a "platform" so failure of one candidate often, but not always… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:PDSB VS S&P 500 (SPY)

NASDAQ:PDSB Summary

Fools bullish on NASDAQ:PDSB are also bullish on:

Fools bearish on NASDAQ:PDSB are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PDSB.

Recs

0
Member Avatar oscillation (70.35) Submitted: 5/13/2018 1:41:02 PM : Outperform Start Price: $9.70 NASDAQ:PDSB Score: -30.66

nev

Recs

0
Member Avatar jed71 (99.86) Submitted: 4/4/2018 10:05:42 AM : Outperform Start Price: $10.50 NASDAQ:PDSB Score: -42.74

This will most likely bounce back to at least equal its cash per share value. I estimate they have ~$80MM remaining in cash after this latest quarter. With 30.9MM outstanding shares, cash per share currently equals around $2.50 per share. This stub does not deserve to be at a 60% discount to cash - that's just ridiculous.

Recs

0
Member Avatar superstar (99.95) Submitted: 4/2/2018 4:00:04 PM : Outperform Start Price: $10.70 NASDAQ:PDSB Score: -43.77

Wow, this is the best buy I've seen in a very long time. Target-- $10+ a solid management team here, and interesting and potentially lucrative pipeline. Disappointing results from a phase III study, NEWTON 2 on lead pipeline candidate, EG-1962-- are not that disappointing at all. No safety concerns and tons of potential.

Leaderboard

Find the members with the highest scoring picks in PDSB.

Score Leader

TrackJimCramer

TrackJimCramer (86.63) Score: +142.42

The Score Leader is the player with the highest score across all their picks in PDSB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Arizard 72.23 6/11/2018 Underperform 5Y $9.80 -24.49% +4.99% +29.48 0 Comment
TheSlightEdge 99.28 3/20/2019 Underperform 3W $8.48 -12.74% +3.76% +16.49 0 Comment
bsge14 98.99 10/11/2018 Outperform 5Y $9.58 -22.77% +6.72% -29.49 0 Comment
TheEgg 39.49 5/14/2018 Outperform 1Y $9.70 -23.71% +6.95% -30.66 0 Comment
oscillation 70.35 5/14/2018 Outperform 5Y $9.70 -23.71% +6.95% -30.66 1 Comment
mcad6641 28.29 5/10/2018 Outperform 5Y $9.92 -25.38% +8.13% -33.51 0 Comment
ababrmon 90.33 5/2/2018 Outperform 5Y $9.82 -24.64% +10.59% -35.24 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. vchelimella < 20 5/8/2018 Outperform 5Y $10.12 -26.86% +9.80% -36.66 0 Comment
BreaKBeatZ 51.29 5/7/2018 Outperform 5Y $10.40 -28.85% +9.26% -38.11 0 Comment
Momentum21 85.48 4/5/2018 Outperform 5Y $10.90 -32.11% +9.71% -41.82 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 86.63 10/7/2015 Underperform 3W $177.90 -95.84% +46.58% +142.42 0 Comment